bg-img9.jpg
8.jpg
A Perspective on "Expanded Access" to Experimental (Cell) Therapies

“Expanded Access,” is a regulatory pathway for physicians to gain access to experimental therapies for patients who usually do not qualify for the clinical trial. This pathway often represents one final chance against a condition that is severely debilitating and/or fatal. Often called “Compassionate Use,” the number of patients and physicians requesting access to experimental therapies has been growing steadily over the past three decades.

Topic: Cold-Chain Logistics, Topic: Cell Therapy S..........

Entrusting Your Biologics with a Service Provider? Important Factors to Consider

Over the past decade, a wave of scientific advances and new technologies have made significant impacts on how medicines are discovered. The drive towards personalized medicine has led to an increased understanding of the molecular and genetic bases of disease. As a result of this increased knowledge, the life sciences industry is shifting its focus from small molecule medicine to biologic medicine, resulting in increased use of biologics in clinical trials and R&D efforts.

Topic: GMP Biologics Management, Content: Blog

Phacilitate Cell and Gene Therapy World 2017: Streamline the path from discovery to cure


The advancements in cell and gene therapy are increasing at a rapid pace and are transforming the way we think about medicine. Whether in research or in the clinic, scientific innovators are acutely aware that every moment counts when working with these valuable therapies. To facilitate knowledge sharing and collaboration, Thermo Fisher Scientific is proud to support Phacilitate Cell & Gene Therapy World 2017 as the Platinum Sponsor.

Topic: Cell Therapy Solutions, Content: Blog

The Evolution of Public Health Research: Malaria, Part 2

Malaria Elimination vs. Eradication, and Genetic Diversity vs. “Freezer Epidemiology”

It is because of its historic mission to eliminate malaria that the CDC is in Atlanta, Georgia. The agency is still deeply involved with the control of malaria, by providing technical assistance around the world, and continuing to protect the US population from the parasite. The CDC estimates that 1,500 people in the USA annually are infected with malaria while traveling, and the CDC tracks these cases and advises the medical community on accurate diagnosis and treatment.

Topic: Public Health Research, The Evolution of Pu..........

Fisher BioServices Top Five Most Popular Blogs of 2016

2016 has been a year filled with new discoveries in the health and medical R&D space. Through our blog, we have shared great stories of our customers' work and discussed a wide-breadth of topics, focusing on cell therapies, biological material, and public health research.

Content: Blog

The Evolution of Public Health Research: Malaria, Part 1

Mosquitoes, the Military, and Why the CDC is in Atlanta

To most of us in the US, malaria is a health problem restricted to distant parts of the globe. Even in the international media, the disease receives little attention. However, it has only been since 1949 that Malaria was declared “eliminated” in the US.

Topic: Public Health Research, The Evolution of Pu..........

Amazing Samples: A Compilation of Stories in Our Cells

Though small, biological samples hold a wealth of information. They are the foundation for the development of new therapies as well as research into the cause of disease.  

Content: eBook, Topic: Amazing Samples

Radiation Therapy for Cancer Treatment is Undergoing a Personalized Medicine Transformation

Personalized medicine, sometimes called precision medicine, has become a major buzzword in the pharmaceutical industry. For decades, scientists and physicians have puzzled over why some treatments are very successful for one patient, while other seemingly similar patients given the same treatment fail to get better. The idea behind personalized medicine is that by characterizing genetic factors, epigenetic information, levels of RNA expression, and other individual factors, we can better target our treatments to the people most likely to respond to them.

Topic: Cell Therapy Solutions

Cell Therapy Manufacturing & Gene Therapy Congress

We are pleased to announce our participation as a sponsor at the upcoming Cell Therapy Manufacturing & Gene Therapy Congress in Amsterdam. The event will focus on connecting cell and gene therapy leads to drive manufacturing and commercialization through direct access to innovative discovery, product development and regulatory know-how. We are honored to showcase our global integrated solution for cell therapy clinical and commercial development in conjunction with our parent company, Thermo Fisher Scientific.

Topic: Cell Therapy Solutions, Content: Blog

Supporting our Troops - Transporting the AFMES DNA Repository to Dover Air Force Base

In observance of the upcoming Veterans Day holiday on November 11, we'd like to share a case study on how the Fisher BioServices team actively supports our troops and share our appreciation for all that they do. Together with our parent company, Thermo Fisher Scientific, we work with veterans to make the world a healthier place.

Topic: Biobanking and Biorepository, Topic: Cold-C..........

Creation of the First Tuberculosis Biobank in the UK

After the discovery of Streptomycin in the 1940s, followed by isoniazid in the 1950s and later rifampin in the 1970s, the incidence of Tuberculosis (TB) in the developed world dropped dramatically. Sanatoria closed and research into new antibiotics and vaccines likewise diminished. TB was no longer considered a significant threat in the US and much of Europe. So when multiple drug-resistant strains of TB (MDR-TB) appeared in the 1980s, the concern within the infectious disease community was perhaps understated. Besides, all but a small number of cases were in underdeveloped countries where the very high cost and difficulty of treating MDR-TB was considered beyond reach.

Topic: Biobanking and Biorepository, Content: Post..........

ISBER Regional Meeting: Quality Biobanking for Precision Research and Medicine

We are pleased to announce our participation at the International Society for Biological and Environmental Repositories (ISBER) 2016 Regional Meeting in Bethesda, Maryland on November 7-8. This year's theme, Quality Biobanking for Precision Research and Medicine, will focus on overcoming scientific, information technology and policy challenges. This regional event allows for greater opportunity for interactions between attendees and a focus on regional issues.

Topic: Biobanking and Biorepository, Topic: Public..........